Report cover image

Global Non-iodinated X-ray Contrast Agents Industry Growth and Trends Forecast to 2031

Publisher APO Research, Inc.
Published Jul 08, 2025
Length 96 Pages
SKU # APRC20339625

Description

Summary

According to APO Research, The global Non-iodinated X-ray Contrast Agents market was estimated at US$ million in 2025 and is projected to reach a revised size of US$ million by 2031, witnessing a CAGR of xx% during the forecast period 2026-2031.

North American market for Non-iodinated X-ray Contrast Agents is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.

Asia-Pacific market for Non-iodinated X-ray Contrast Agents is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.

Europe market for Non-iodinated X-ray Contrast Agents is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.

The major global manufacturers of Non-iodinated X-ray Contrast Agents include Bracco Diagnostics, Guerbet Group, Qinhuangdao Zizhu Pharmaceutical Co., Ltd., Qingdao Hongdie New Materials Co., Ltd., Shandong Shengli Pharmaceutical Co., Ltd., Taishan Xinning Pharmaceutical Co., Ltd. and Xi'an Disai Biopharmaceutical Co., Ltd., etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Non-iodinated X-ray Contrast Agents, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Non-iodinated X-ray Contrast Agents.
The Non-iodinated X-ray Contrast Agents market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Non-iodinated X-ray Contrast Agents market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

Key Companies & Market Share Insights

In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2020-2025. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses.

Non-iodinated X-ray Contrast Agents Segment by Company

Bracco Diagnostics
Guerbet Group
Qinhuangdao Zizhu Pharmaceutical Co., Ltd.
Qingdao Hongdie New Materials Co., Ltd.
Shandong Shengli Pharmaceutical Co., Ltd.
Taishan Xinning Pharmaceutical Co., Ltd.
Xi'an Disai Biopharmaceutical Co., Ltd.
Non-iodinated X-ray Contrast Agents Segment by Type

Barium Sulfate Type I
Barium Sulfate Type II
Non-iodinated X-ray Contrast Agents Segment by Application

Hospital
Clinic
Other
Non-iodinated X-ray Contrast Agents Segment by Region

North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Non-iodinated X-ray Contrast Agents market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Non-iodinated X-ray Contrast Agents and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Non-iodinated X-ray Contrast Agents.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Non-iodinated X-ray Contrast Agents manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Non-iodinated X-ray Contrast Agents in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.

Table of Contents

96 Pages
1 Market Overview
1.1 Product Definition
1.2 Global Market Growth Prospects
1.2.1 Global Non-iodinated X-ray Contrast Agents Market Size Estimates and Forecasts (2020-2031)
1.2.2 Global Non-iodinated X-ray Contrast Agents Sales Estimates and Forecasts (2020-2031)
1.3 Non-iodinated X-ray Contrast Agents Market by Type
1.3.1 Barium Sulfate Type I
1.3.2 Barium Sulfate Type II
1.4 Global Non-iodinated X-ray Contrast Agents Market Size by Type
1.4.1 Global Non-iodinated X-ray Contrast Agents Market Size Overview by Type (2020-2031)
1.4.2 Global Non-iodinated X-ray Contrast Agents Historic Market Size Review by Type (2020-2025)
1.4.3 Global Non-iodinated X-ray Contrast Agents Forecasted Market Size by Type (2026-2031)
1.5 Key Regions Market Size by Type
1.5.1 North America Non-iodinated X-ray Contrast Agents Sales Breakdown by Type (2020-2025)
1.5.2 Europe Non-iodinated X-ray Contrast Agents Sales Breakdown by Type (2020-2025)
1.5.3 Asia-Pacific Non-iodinated X-ray Contrast Agents Sales Breakdown by Type (2020-2025)
1.5.4 South America Non-iodinated X-ray Contrast Agents Sales Breakdown by Type (2020-2025)
1.5.5 Middle East and Africa Non-iodinated X-ray Contrast Agents Sales Breakdown by Type (2020-2025)
2 Global Market Dynamics
2.1 Non-iodinated X-ray Contrast Agents Industry Trends
2.2 Non-iodinated X-ray Contrast Agents Industry Drivers
2.3 Non-iodinated X-ray Contrast Agents Industry Opportunities and Challenges
2.4 Non-iodinated X-ray Contrast Agents Industry Restraints
3 Market Competitive Landscape by Company
3.1 Global Top Players by Non-iodinated X-ray Contrast Agents Revenue (2020-2025)
3.2 Global Top Players by Non-iodinated X-ray Contrast Agents Sales (2020-2025)
3.3 Global Top Players by Non-iodinated X-ray Contrast Agents Price (2020-2025)
3.4 Global Non-iodinated X-ray Contrast Agents Industry Company Ranking, 2023 VS 2024 VS 2025
3.5 Global Non-iodinated X-ray Contrast Agents Major Company Production Sites & Headquarters
3.6 Global Non-iodinated X-ray Contrast Agents Company, Product Type & Application
3.7 Global Non-iodinated X-ray Contrast Agents Company Establishment Date
3.8 Market Competitive Analysis
3.8.1 Global Non-iodinated X-ray Contrast Agents Market CR5 and HHI
3.8.2 Global Top 5 and 10 Non-iodinated X-ray Contrast Agents Players Market Share by Revenue in 2024
3.8.3 2023 Non-iodinated X-ray Contrast Agents Tier 1, Tier 2, and Tier 3
4 Non-iodinated X-ray Contrast Agents Regional Status and Outlook
4.1 Global Non-iodinated X-ray Contrast Agents Market Size and CAGR by Region: 2020 VS 2024 VS 2031
4.2 Global Non-iodinated X-ray Contrast Agents Historic Market Size by Region
4.2.1 Global Non-iodinated X-ray Contrast Agents Sales in Volume by Region (2020-2025)
4.2.2 Global Non-iodinated X-ray Contrast Agents Sales in Value by Region (2020-2025)
4.2.3 Global Non-iodinated X-ray Contrast Agents Sales (Volume & Value), Price and Gross Margin (2020-2025)
4.3 Global Non-iodinated X-ray Contrast Agents Forecasted Market Size by Region
4.3.1 Global Non-iodinated X-ray Contrast Agents Sales in Volume by Region (2026-2031)
4.3.2 Global Non-iodinated X-ray Contrast Agents Sales in Value by Region (2026-2031)
4.3.3 Global Non-iodinated X-ray Contrast Agents Sales (Volume & Value), Price and Gross Margin (2026-2031)
5 Non-iodinated X-ray Contrast Agents by Application
5.1 Non-iodinated X-ray Contrast Agents Market by Application
5.1.1 Hospital
5.1.2 Clinic
5.1.3 Other
5.2 Global Non-iodinated X-ray Contrast Agents Market Size by Application
5.2.1 Global Non-iodinated X-ray Contrast Agents Market Size Overview by Application (2020-2031)
5.2.2 Global Non-iodinated X-ray Contrast Agents Historic Market Size Review by Application (2020-2025)
5.2.3 Global Non-iodinated X-ray Contrast Agents Forecasted Market Size by Application (2026-2031)
5.3 Key Regions Market Size by Application
5.3.1 North America Non-iodinated X-ray Contrast Agents Sales Breakdown by Application (2020-2025)
5.3.2 Europe Non-iodinated X-ray Contrast Agents Sales Breakdown by Application (2020-2025)
5.3.3 Asia-Pacific Non-iodinated X-ray Contrast Agents Sales Breakdown by Application (2020-2025)
5.3.4 South America Non-iodinated X-ray Contrast Agents Sales Breakdown by Application (2020-2025)
5.3.5 Middle East and Africa Non-iodinated X-ray Contrast Agents Sales Breakdown by Application (2020-2025)
6 Company Profiles
6.1 Bracco Diagnostics
6.1.1 Bracco Diagnostics Comapny Information
6.1.2 Bracco Diagnostics Business Overview
6.1.3 Bracco Diagnostics Non-iodinated X-ray Contrast Agents Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Bracco Diagnostics Non-iodinated X-ray Contrast Agents Product Portfolio
6.1.5 Bracco Diagnostics Recent Developments
6.2 Guerbet Group
6.2.1 Guerbet Group Comapny Information
6.2.2 Guerbet Group Business Overview
6.2.3 Guerbet Group Non-iodinated X-ray Contrast Agents Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Guerbet Group Non-iodinated X-ray Contrast Agents Product Portfolio
6.2.5 Guerbet Group Recent Developments
6.3 Qinhuangdao Zizhu Pharmaceutical Co., Ltd.
6.3.1 Qinhuangdao Zizhu Pharmaceutical Co., Ltd. Comapny Information
6.3.2 Qinhuangdao Zizhu Pharmaceutical Co., Ltd. Business Overview
6.3.3 Qinhuangdao Zizhu Pharmaceutical Co., Ltd. Non-iodinated X-ray Contrast Agents Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Qinhuangdao Zizhu Pharmaceutical Co., Ltd. Non-iodinated X-ray Contrast Agents Product Portfolio
6.3.5 Qinhuangdao Zizhu Pharmaceutical Co., Ltd. Recent Developments
6.4 Qingdao Hongdie New Materials Co., Ltd.
6.4.1 Qingdao Hongdie New Materials Co., Ltd. Comapny Information
6.4.2 Qingdao Hongdie New Materials Co., Ltd. Business Overview
6.4.3 Qingdao Hongdie New Materials Co., Ltd. Non-iodinated X-ray Contrast Agents Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Qingdao Hongdie New Materials Co., Ltd. Non-iodinated X-ray Contrast Agents Product Portfolio
6.4.5 Qingdao Hongdie New Materials Co., Ltd. Recent Developments
6.5 Shandong Shengli Pharmaceutical Co., Ltd.
6.5.1 Shandong Shengli Pharmaceutical Co., Ltd. Comapny Information
6.5.2 Shandong Shengli Pharmaceutical Co., Ltd. Business Overview
6.5.3 Shandong Shengli Pharmaceutical Co., Ltd. Non-iodinated X-ray Contrast Agents Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Shandong Shengli Pharmaceutical Co., Ltd. Non-iodinated X-ray Contrast Agents Product Portfolio
6.5.5 Shandong Shengli Pharmaceutical Co., Ltd. Recent Developments
6.6 Taishan Xinning Pharmaceutical Co., Ltd.
6.6.1 Taishan Xinning Pharmaceutical Co., Ltd. Comapny Information
6.6.2 Taishan Xinning Pharmaceutical Co., Ltd. Business Overview
6.6.3 Taishan Xinning Pharmaceutical Co., Ltd. Non-iodinated X-ray Contrast Agents Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Taishan Xinning Pharmaceutical Co., Ltd. Non-iodinated X-ray Contrast Agents Product Portfolio
6.6.5 Taishan Xinning Pharmaceutical Co., Ltd. Recent Developments
6.7 Xi'an Disai Biopharmaceutical Co., Ltd.
6.7.1 Xi'an Disai Biopharmaceutical Co., Ltd. Comapny Information
6.7.2 Xi'an Disai Biopharmaceutical Co., Ltd. Business Overview
6.7.3 Xi'an Disai Biopharmaceutical Co., Ltd. Non-iodinated X-ray Contrast Agents Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Xi'an Disai Biopharmaceutical Co., Ltd. Non-iodinated X-ray Contrast Agents Product Portfolio
6.7.5 Xi'an Disai Biopharmaceutical Co., Ltd. Recent Developments
7 North America by Country
7.1 North America Non-iodinated X-ray Contrast Agents Sales by Country
7.1.1 North America Non-iodinated X-ray Contrast Agents Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
7.1.2 North America Non-iodinated X-ray Contrast Agents Sales by Country (2020-2025)
7.1.3 North America Non-iodinated X-ray Contrast Agents Sales Forecast by Country (2026-2031)
7.2 North America Non-iodinated X-ray Contrast Agents Market Size by Country
7.2.1 North America Non-iodinated X-ray Contrast Agents Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
7.2.2 North America Non-iodinated X-ray Contrast Agents Market Size by Country (2020-2025)
7.2.3 North America Non-iodinated X-ray Contrast Agents Market Size Forecast by Country (2026-2031)
8 Europe by Country
8.1 Europe Non-iodinated X-ray Contrast Agents Sales by Country
8.1.1 Europe Non-iodinated X-ray Contrast Agents Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
8.1.2 Europe Non-iodinated X-ray Contrast Agents Sales by Country (2020-2025)
8.1.3 Europe Non-iodinated X-ray Contrast Agents Sales Forecast by Country (2026-2031)
8.2 Europe Non-iodinated X-ray Contrast Agents Market Size by Country
8.2.1 Europe Non-iodinated X-ray Contrast Agents Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
8.2.2 Europe Non-iodinated X-ray Contrast Agents Market Size by Country (2020-2025)
8.2.3 Europe Non-iodinated X-ray Contrast Agents Market Size Forecast by Country (2026-2031)
9 Asia-Pacific by Country
9.1 Asia-Pacific Non-iodinated X-ray Contrast Agents Sales by Country
9.1.1 Asia-Pacific Non-iodinated X-ray Contrast Agents Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
9.1.2 Asia-Pacific Non-iodinated X-ray Contrast Agents Sales by Country (2020-2025)
9.1.3 Asia-Pacific Non-iodinated X-ray Contrast Agents Sales Forecast by Country (2026-2031)
9.2 Asia-Pacific Non-iodinated X-ray Contrast Agents Market Size by Country
9.2.1 Asia-Pacific Non-iodinated X-ray Contrast Agents Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
9.2.2 Asia-Pacific Non-iodinated X-ray Contrast Agents Market Size by Country (2020-2025)
9.2.3 Asia-Pacific Non-iodinated X-ray Contrast Agents Market Size Forecast by Country (2026-2031)
10 South America by Country
10.1 South America Non-iodinated X-ray Contrast Agents Sales by Country
10.1.1 South America Non-iodinated X-ray Contrast Agents Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
10.1.2 South America Non-iodinated X-ray Contrast Agents Sales by Country (2020-2025)
10.1.3 South America Non-iodinated X-ray Contrast Agents Sales Forecast by Country (2026-2031)
10.2 South America Non-iodinated X-ray Contrast Agents Market Size by Country
10.2.1 South America Non-iodinated X-ray Contrast Agents Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
10.2.2 South America Non-iodinated X-ray Contrast Agents Market Size by Country (2020-2025)
10.2.3 South America Non-iodinated X-ray Contrast Agents Market Size Forecast by Country (2026-2031)
11 Middle East and Africa by Country
11.1 Middle East and Africa Non-iodinated X-ray Contrast Agents Sales by Country
11.1.1 Middle East and Africa Non-iodinated X-ray Contrast Agents Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
11.1.2 Middle East and Africa Non-iodinated X-ray Contrast Agents Sales by Country (2020-2025)
11.1.3 Middle East and Africa Non-iodinated X-ray Contrast Agents Sales Forecast by Country (2026-2031)
11.2 Middle East and Africa Non-iodinated X-ray Contrast Agents Market Size by Country
11.2.1 Middle East and Africa Non-iodinated X-ray Contrast Agents Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
11.2.2 Middle East and Africa Non-iodinated X-ray Contrast Agents Market Size by Country (2020-2025)
11.2.3 Middle East and Africa Non-iodinated X-ray Contrast Agents Market Size Forecast by Country (2026-2031)
12 Value Chain and Sales Channels Analysis
12.1 Non-iodinated X-ray Contrast Agents Value Chain Analysis
12.1.1 Non-iodinated X-ray Contrast Agents Key Raw Materials
12.1.2 Key Raw Materials Price
12.1.3 Raw Materials Key Suppliers
12.1.4 Manufacturing Cost Structure
12.1.5 Non-iodinated X-ray Contrast Agents Production Mode & Process
12.2 Non-iodinated X-ray Contrast Agents Sales Channels Analysis
12.2.1 Direct Comparison with Distribution Share
12.2.2 Non-iodinated X-ray Contrast Agents Distributors
12.2.3 Non-iodinated X-ray Contrast Agents Customers
13 Concluding Insights
14 Appendix
14.1 Reasons for Doing This Study
14.2 Research Methodology
14.3 Research Process
14.4 Authors List of This Report
14.5 Data Source
14.5.1 Secondary Sources
14.5.2 Primary Sources
14.6 Disclaimer
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.